|
Resolution: standard / high Figure 3.
Aberrant karyotype was predictor of death in t-AML, but not in t-MDS patients. Survival was studied according to the presence of any cytogenetic aberrations versus
normal karyotype
Fianchi et al. Journal of Hematology & Oncology 2012 5:44 doi:10.1186/1756-8722-5-44 |
